Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

Janus Kinase Inhibitor [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0002-4182 Olumiant baricitinib Eli Lilly and Company TABLET, FILM COATED 2018-05-31
0002-4479 Olumiant baricitinib Eli Lilly and Company TABLET, FILM COATED 2022-05-10
0002-4732 Olumiant baricitinib Eli Lilly and Company TABLET, FILM COATED 2019-10-08
0002-6885 Baricitinib baricitinib Eli Lilly and Company TABLET, FILM COATED 2021-12-20
0069-0235 Cibinqo abrocitinib Pfizer Laboratories Div Pfizer Inc TABLET, FILM COATED 2022-02-24
0069-0335 Cibinqo abrocitinib Pfizer Laboratories Div Pfizer Inc TABLET, FILM COATED 2022-02-24
0069-0435 Cibinqo abrocitinib Pfizer Laboratories Div Pfizer Inc TABLET, FILM COATED 2022-02-24
0074-1043 Rinvoq Upadacitinib AbbVie Inc. TABLET, EXTENDED RELEASE 2019-08-16
0074-2306 Rinvoq Upadacitinib AbbVie Inc. TABLET, EXTENDED RELEASE 2019-08-16
0074-2310 Rinvoq Upadacitinib AbbVie Inc. TABLET, EXTENDED RELEASE 2019-08-16
0074-2320 Rinvoq Upadacitinib AbbVie Inc. SOLUTION 2024-04-26
50222-280 Anzupgo delgocitinib LEO Pharma, Inc CREAM 2025-07-24
50881-005 JAKAFI ruxolitinib Incyte Corporation TABLET 2011-11-16
50881-010 JAKAFI ruxolitinib Incyte Corporation TABLET 2011-11-16
50881-015 JAKAFI ruxolitinib Incyte Corporation TABLET 2011-11-16
50881-020 JAKAFI ruxolitinib Incyte Corporation TABLET 2011-11-16
50881-025 JAKAFI ruxolitinib Incyte Corporation TABLET 2011-11-16
63539-236 CIBINQO abrocitinib U.S. Pharmaceuticals TABLET, FILM COATED 2022-02-24
63539-336 CIBINQO abrocitinib U.S. Pharmaceuticals TABLET, FILM COATED 2022-02-24
63539-436 CIBINQO abrocitinib U.S. Pharmaceuticals TABLET, FILM COATED 2022-02-24



 [EPC] Established Pharmacological Classification 

Loading full table content...